MedTech News
.................... by Andrew Celentano
Study uncovers why some immunotherapy-treated tumors may grow faster
A new Northwestern Medicine study has uncovered a biological mechanism that may explain why a subset of tumors unexpectedly grows at an accelerated rate after being treated with certain immunotherapies, according to findings published in the journal Cancer Discovery.
AI-assisted approach helps novice users capture heart ultrasound images and identify aortic stenosis
Mayo Clinic researchers tested an approach that uses artificial intelligence (AI) to help people without previous ultrasound experience capture heart images and identify patients who may have a common and serious heart valve condition.
Hydrogel-grown tumors could speed cancer drug testing, reduce animal use
A review by University of Manchester scientists says sophisticated lab-grown tumors could help fast-track the search for new cancer treatments while reducing reliance on animal testing.
Cancer cells release antioxidants to prevent immune cells from destroying them
Molecules called reactive oxygen species, which include so-called “free radicals,” have long been viewed as damaging byproducts of our body’s metabolism—a reason antioxidant supplements have been considered a potential way to reduce cancer risk.
Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems
New FDA clearances expand Hamamatsu’s FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions.
Bayesian Health’s FDA-Cleared Continuous AI Sepsis Monitor
Beginning October 1, 2026, hospitals using Bayesian’s continuous sepsis monitor can receive additional Medicare reimbursement for eligible inpatient cases, the first reimbursement pathway of its kind for presuspicion sepsis monitoring.
FDA grants 510(k) clearance to Medibyt’s CPETWise solution
CPETWise automates and standardises CPET workflow, transforming complex physiological data into streamlined processes.
Vara nets first CE mark for autonomous AI breast cancer screening tool
The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedded into the cancer screening paradigm.